nCounter® Immunology Panel
Helping Your Research
Perform multiplex gene expression analysis in human or mouse with over 500 general immunology genes. The nCounter Immunology Panel includes major classes of cytokines and their receptors, enzymes with specific gene families such as the major chemokine ligands and receptors, interferons and their receptors, the TNF-receptor superfamily, and the KIR family genes.
- Ideal for the study of allergy, autoimmune diseases, and the immune response to infectious disease
- Unique mouse genes address known differences such as unique receptor ligands, Ig receptors and chemokines
- Customizable with up to 55 additional user-defined genes with the Panel Plus option
Panel Selection Tool
Find the gene expression panel for your research with Panel Pro
Find Your Panel
Product Information
Publications
Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis
Ulcerative colitis (UC) is driven by immune and stromal subsets, culminating in epithelial injury. Vedolizumab (VDZ) is an anti-integrin antibody that is effective for treating UC.
In situ single-cell profiling sheds light on IFI27 localisation during SARS-CoV-2 infection
The utilization of single-cell resolved spatial transcriptomics to delineate immune responses during SARS-CoV-2 infection was able to identify M1 macrophages to have elevated expression of IFI27 in areas of infection.
The SARS-CoV-2 pandemic has affected over 600 million people to date, resulting in over 6.
Whole transcriptome profiling of placental pathobiology in SARS‐CoV‐2 pregnancies identifies placental dysfunction signatures
Objectives: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) virus infection in pregnancy is associated with higher incidence of placental dysfunction, referred to by a few studies as a ‘preeclampsia‐like syndrome’. However, the mechanisms underpinning SARS‐CoV‐2‐induced placental malfunction are still unclear.
Request a Quote
Contact our helpful experts and we’ll be in touch soon.
